During the 1990s, MSF teams made a bitter observation: we were failing to treat some of our patients suffering from infectious diseases, while in developed countries, remarkable progress was being made in the field of health. Two decades on, medicines in developing countries are still either too expensive, aren't suitable to be used in many of the contexts in which we work (for example, in hot, humid conditions or where there's a lack of electricity), or simply don't exist for the diseases we need to treat.
In 1999, we launched the Campaign for Access to Essential Medicines, now known as the Access Campaign. Its mission focuses on three areas: overcoming barriers to access to essential medicines, stimulating research and development for neglected diseases, promoting health exceptions to global trade agreements.
In 2003, MSF joined several research institutes, including the Institut Pasteur, to create the Drugs for Neglected Diseases initiative (DNDi), a non-profit research and development organisation engaged in research and development of new treatments for neglected diseases.
![Treating multi drug resistant TB and HIV/AIDS in Manipur, India Treating multi drug resistant TB and HIV/AIDS in Manipur, India](https://img.msf.org/Docs/MSF/Media/CMS3/7/b/8/b/MSF127803.jpg)
MSF urges PM to resist US patent pressure
![Tsholotsho. Community ART Groups (CAG) Tsholotsho. Community ART Groups (CAG)](https://img.msf.org/AssetLink/e24214rs7mt1487h5awajw61aux0880j.jpg)
Community ART groups lighten the load for HIV patients
![Viral Load Viral Load](https://img.msf.org/AssetLink/i2h86pv1u01jix25h26vm4e2186j8n1u.jpg)
High prices hinder access to newer HIV drugs and optimal tests that ensure treatment is working
![Cameroon - Buruli Ulcer sensitization week Cameroon - Buruli Ulcer sensitization week](https://img.msf.org/AssetLink/176w37g54mbo1r7k82ikevs253ed702q.jpg)
"We're in the process of writing a page of medical history"
![Maban, South Sudan Maban, South Sudan](https://img.msf.org/Docs/MSF/Media/CMS3/0/3/8/2/MSF135301.jpg)
Where is everyone?
Outcomes of antiretroviral therapy over a 10-year period of expansion: a multicohort analysis of African and Asian HIV programmes
![Siyabulela Qwaka, XDR TB Survivor Siyabulela Qwaka, XDR TB Survivor](https://img.msf.org/AssetLink/m11ncbj73gbef4o028o6ohe0ur4qg1d3.jpg)